NeuroQore, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-29.
NeuroQore, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 29, 2025. The filing reports $1.51M sold. Its industry group is Biotechnology. It names Mehran Talebinejad (Executive Officer, Director), Adrian Chan (Executive Officer, Director) (SEC Form D, September 29, 2025).
Is this your company?
Sell to companies like NeuroQore, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns NeuroQore, Inc.
Free to see. No signup.
More on the people and the money behind NeuroQore, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in September 2025, largest first.
Get an email when NeuroQore, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when NeuroQore, Inc. raises, hires or launches. No email unless you switch it on.
Watch NeuroQore, Inc. →Get the full cited report on NeuroQore, Inc.
What the filing shows about NeuroQore, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on NeuroQore, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives NeuroQore, Inc.'s address as 201 Jason Way, Mountain View, CA 94043.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
NeuroQore, Inc. is a registered filer with the SEC (CIK 2080144) and has filed since 2025-09-29. 1 filing is on record, the latest on 2025-09-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
NeuroQore, Inc.'s Form D of 2025-09-29 names Mehran Talebinejad and Adrian Chan as its officers, directors or promoters.
Its new offerings report $1.51M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Mehran Talebinejad is named as Executive Officer and Director on the Form D that NeuroQore, Inc. filed with the SEC on 29 September 2025, one of 2 people that filing names.
Adrian Chan is named as Executive Officer and Director on the Form D that NeuroQore, Inc. filed with the SEC on 29 September 2025, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2025-09-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about NeuroQore, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on NeuroQore, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on NeuroQore, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist NeuroQore, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind NeuroQore, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for NeuroQore, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/neuroqore-inc-form-d-25000001